A cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC; IC
50 = 7.9 nM for rat brain). Selectively inhibits Ca
2+-dependent PKC α-isozyme (IC
50 = 2.3 nM) and PKC
βI (IC
50 = 6.2 nM). Does not affect the kinase activity of the Ca
2+-independent PKC δ-, ε-, and ζ-isozymes even at micromolar levels. Reported to inhibit PKC
µ at higher concentrations (IC
50 = 20 nM). A 500 µg/ml solution of Gö 6976 (
Cat. No. 365253) in anhydrous DMSO is also available.
|
Product information
|
|
Form
|
Off-white solid
|
|
Primary Target
|
PKC
|
|
Primary Target IC50
|
7.9 nM
|
|
Secondary target
|
Ca2+-dependent PKC α-isozyme (IC50 = 2.3 nM) and PKCβI (IC50 = 6.2 nM) , PKCµ at higher concentrations IC50 = 20 nM
|
|
Molar mass
|
378.4
|
|
Protect from Light
|
Yes
|
|
Purity
|
≥95% by HPLC
|
|
Solubility
|
DMSO
|
|
Chemical formula
|
C24H18N4O
|
|
CAS number
|
136194-77-9
|
|
Declaration
|
Sold under license of U.S. Patent 5,489,608 and European Patent 0,434,057.
|
|
Store and ship information
|
|
|
|
Storage
|
+2°C to +8°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|